Symposium on the Contributions by Anthony Nolan to HSCT and the Current Status of Innovative Cell Therapies

Thursday 11th March 2021
Virtual Event

Videos

Welcome and Overview of 27 years of ANRI

Welcome
Professor Antonio Pagliuca, King’s College Hospital NHS Foundation Trust, London

Overview of 27 years of ANRI
Professor Alejandro Madrigal, Ex-Scientific Director Anthony Nolan

Alejandro Madrigal: a remarkable contribution to global transplantation
Honoured guests

Innovative Therapies in Haematopoietic Malignancies

Chairs: Professor John Snowden and Professor Antonio Pagliuca

Introduction
Professor Antonio Pagliuca, King’s College Hospital NHS Foundation Trust, London

Multiple myeloma and CAR-T cells
Professor Hermann Einsele, Julius Maximilians University, Wurzburg, Germany

CAR-T cells for acute leukaemia
Professor Mohamad Mohty, Saint-Antoine Hospital and University Pierre & Marie Curie, Paris, France

Access to CAR-T cell therapy in real-life
Professor Rafael Duarte, University Hospital Puerta de Hierro, Majadahonda, Madrid, Spain

Novel therapies for and after HSCT

Chairs: Professor Charles Craddock and Professor David Marks

Introduction
Professor David Marks, University Hospitals Bristol NHS Foundation Trust

New drugs for the treatment of GvHD
Prof Nicolaus Kroeger, President EBMT, University Hospital Hamburg-Eppendorf, Germany

Universal CAR-T cells
Professor Paul Veys, Great Ormond Street Hospital for Children NHS Foundation Trust & University College London

Future use of T cells as treatment for leukaemia beyond CAR-T cells
Professor Fred Falkenburg, Leiden University Medical Centre, The Netherlands

Future Challenges

Chairs: Professor John Barrett and Dr Robert Danby (Anthony Nolan)

Introduction
Professor John Barrett, George Washington University Cancer Centre, Washington, USA

New drugs for the treatment of CMV and viral infections
Professor Per Ljungman, Karolinska University Hospital, Stockholm, Sweden

Activating natural killer cells for immunotherapy
Professor Salim Khakoo, University of Southampton

The whole genomic analysis for patient and donor in stem cell transplantation
Professor Rafael Arguello, University Autonoma of Coahuila, Torreon, Mexico

Immunogenetics and the Search for the Optimal Donor

Chairs: Professor Steven Marsh (Anthony Nolan and UCL) and Dr Kim Orchard (University Hospital Southampton)

Introduction
Dr Kim Orchard

New cancer therapies: are haematopoietic cell transplants a dead duck?
Professor Robert Peter Gale, UCLA and Imperial College

The role of international outcome registries
Dr Bronwen Shaw, CIBMTR and Froedtert and Medical College of Wisconsin, Milwaukee, USA

Impact of new genetic discoveries on HSCT
Professor Effie Petersdorf, University of Washington, USA

Cord blood banking: transplantation and beyond
Dr Sergio Querol, Blood and Tissue Bank, Barcelona, Spain

Innovative approaches to CB transplantation for haematological malignancies
Dr Juliet Barker, Memorial Sloan Kettering Cancer Centre, New York, USA

Concluding remarks and acknowledgements
Prof Charles Craddock, University Hospitals Birmingham NHS Foundation Trust
Ms Henny Braund, Anthony Nolan